These findings are consistent with studies reported that the presence of NAFLD is independently associated with severe COVID-19 (24, 28–30) independent of obesity (31), especially those the presence of liver fibrosis (32) and with high serum interleukin-6 (IL-6) levels (33). This evidence concerns the gene IL6 and obesity disorder.